• REWA SOOD M. D. Psychiatry, Regional Hospital Una, India
  • GAGANDEEP AHUJA M. D. Psychiatry, Dr YSPGMC, Nahan, India
  • SHIVAM SHARMA Department of Psychiatry, AIIMS Bilaspur, India
  • DINESH DUTT SHARMA Department of Psychiatry, IGMC, Shimla, India
  • MONICA 5Department of Medicine, DMC Ludhiana, India
  • SACHIN M. D. Psychiatry, Dr YSPGMC, Nahan, India
  • MALAY SARKAR Department of Pulmonary Medicine, IGMC, Shimla, India



COPD, Comorbidities, Anxiety and Depression, Cross-sectional Study, Psychiatric Co-morbidities


Objective: COPD often exists with comorbidities that may have a significant impact on prognosis. Patients with COPD are predisposed to both cognitive and psychiatric disorders. Anxiety and depression are common and important comorbidities in patients with chronic obstructive pulmonary disease (COPD). Regarding this, there is a lack of data from state of Himachal Pradesh.

Methods: Our study was a cross-sectional study wherein 100 patients who attended the Pulmonary Medicine outpatient clinic of IGMC, Shimla were recruited. Patients were evaluated using tools International Classification of Disease, 10threvision, MINI 6.0, Addenbrooke's Cognitive Examination, Hamilton Anxiety Rating Scale, Hamilton Depression Rating Scale.

Results: About two-third (62%) of the patients were found to have psychiatric co-morbidities. The most common psychiatric co-morbidity was found to be mixed anxiety and depression in 20% of the patients followed by unspecified anxiety disorder in 12% of the patients,9% of the patients were diagnosed with dementia while 6% were found to have a major depressive disorder. As per our observation, the severity of anxiety and depressive symptoms as per the HARS scale and HAMD scales, respectively, increased as the severity of the disease increased.

Conclusion: The present study shows that about two third (62%) of the patients were found to have psychiatric co-morbidities. Psychiatric comorbidities have a significant impact on quality of life, exacerbation frequency and survival. Another multicentre large observational study can be planned in the future to overcome the above problems.


Download data is not yet available.


Halpin DMG, Celli BR, Criner GJ, Frith P, Lopez Varela MV, Salvi S. The GOLD summit on chronic obstructive pulmonary disease in low-and middle-income countries. Int J Tuberc Lung Dis. 2019 Nov 1;23(11):1131-41. doi: 10.5588/ijtld.19.0397, PMID 31718748.

Putcha N, Puhan MA, Hansel NN, Drummond MB, Boyd CM. Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001-2008. COPD J Chronic Obstruct Pulm Dis. 2013 Jun 1;10(3):324-32. doi: 10.3109/15412555.2012.744963, PMID 23713595.

Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto Plata V. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012 Jul 15;186(2):155-61. doi: 10.1164/rccm.201201-0034OC, PMID 22561964.

Charlson M, Charlson RE, Briggs W, Hollenberg J. Can disease management target patients most likely to generate high costs? The impact of comorbidity. J Gen Intern Med. 2007 Apr 1;22(4):464-9. doi: 10.1007/s11606-007-0130-7, PMID 17372794.

Shim TS, Lee JH, Kim SY, Lim TH, Kim SJ, Kim DS. Cerebral metabolic abnormalities in COPD patients detected by localized proton magnetic resonance spectroscopy. Chest. 2001 Nov 1;120(5):1506-13. doi: 10.1378/chest.120.5.1506, PMID 11713127.

Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998 Jan 1;59(20)Suppl 20:22-34. PMID 9881538.

World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization; 1992.

Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi: 10.1136/jnnp.23.1.56, PMID 14399272.

Hamilton MA. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-5. doi: 10.1111/j.2044-8341.1959.tb00467.x, PMID 13638508.

Hodges JR, Larner AJ. Addenbrooke’s cognitive examinations: ace, ace-r, ace-iii, ace app, and m-ace. In: Cognitive screening instruments; 2017. p. 109-37.

Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLOS Med. 2006 Nov 28;3(11):e442. doi: 10.1371/journal.pmed.0030442, PMID 17132052.

Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006 Sep 1;28(3):523-32. doi: 10.1183/09031936.06.00124605, PMID 16611654.

Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J. 2008 Jan 1;31(1):204-12. doi: 10.1183/09031936.00114307, PMID 18166598.

Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008 Oct 1;134(4)Suppl:43S-56S. doi: 10.1378/chest.08-0342, PMID 18842932.

Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008 Oct 1;32(4):962-9. doi: 10.1183/09031936.00012408, PMID 18579551.

Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007 Jan 8;167(1):60-7. doi: 10.1001/archinte.167.1.60, PMID 17210879.

Charlson M, Charlson RE, Briggs W, Hollenberg J. Can disease management target patients most likely to generate high costs? The impact of comorbidity. J Gen Intern Med. 2007 Apr 1;22(4):464-9. doi: 10.1007/s11606-007-0130-7, PMID 17372794.

Chaudhary SC, Nanda S, Tripathi A, Sawlani KK, Gupta KK, Himanshu D. Prevalence of psychiatric comorbidities in chronic obstructive pulmonary disease patients. Lung India Off Organ Indian Chest Soc. 2016 Mar;33(2):174-8. doi: 10.4103/0970-2113.177441, PMID 27051106.

Rosinczuk J, Przyszlak M, Uchmanowicz I. Sociodemographic and clinical factors affecting the quality of life of patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2018;13:2869-82. doi: 10.2147/COPD.S165714, PMID 30254434.

Suerdem M, Gunen H, Akyildiz L, Cilli A, Ozlu T, Uzaslan E. Demographic, clinical and management characteristics of newly diagnosed COPD patients in turkey: a real-life study. Int J Chron Obstruct Pulmon Dis. 2020;15:261-7. doi: 10.2147/COPD.S211838, PMID 32103925.

Ahmed MS, Neyaz A, Aslami AN. Health-related quality of life of chronic obstructive pulmonary disease patients: results from a community-based cross-sectional study in Aligarh, Uttar Pradesh, India. Lung India off Organ Indian Chest Soc. 2016 Mar;33(2):148-53. doi: 10.4103/0970-2113.177438, PMID 27051101.

Abad Corpa E, Royo Morales T, Iniesta Sanchez J, Rodriguez Mondejar JJ, Carrillo Alcaraz A, Perez Garcia MC. A descriptive study of the socio-demographic and clinical profile of the patient with chronic obstructive pulmonary disease. Enferm Clin. 2011 Jan 1;21(1):12-8. doi: 10.1016/j.enfcli.2010.10.002, PMID 21333577.

Rossi Ferrario S, Cremona G. Communication in a medical setting: can standards be improved? Multidiscip Respir Med. 2013;8(1):1. doi: 10.1186/2049-6958-8-1, PMID 23295153.

Janssen DJ, Spruit MA, Leue C, Gijsen C, Hameleers H, Schols JM. Symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation. Chron Respir Dis. 2010 Aug;7(3):147-57. doi: 10.1177/1479972310369285, PMID 20688892.

Lou P, Zhu Y, Chen P, Zhang P, Yu J. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case-control study. BMC Pulm Med. 2012 Dec;12(1):1-9.

Sharma BB, Singh S, Sharma VK, Choudhary M, Singh V, Lane S. Psychiatric morbidity in chronic respiratory disorders in an Indian service using GMHAT/PC. Gen Hosp Psychiatry. 2013 Jan 1;35(1):39-44. doi: 10.1016/j.genhosppsych.2012.09.009, PMID 23122486.

Kahraman H, Orhan FO, Sucakli MH, Ozer A, Koksal N, Sen B. Temperament and character profiles of male COPD patients. J Thorac Dis. 2013;5(4):406-13. doi: 10.3978/j.issn.2072-1439.2013.07.11, PMID 23991295.

Hynninen KM, Breitve MH, Wiborg AB, Pallesen S, Nordhus IH. Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. J Psychosom Res. 2005 Dec 1;59(6):429-43. doi: 10.1016/j.jpsychores.2005.04.007, PMID 16310027.

Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014 Sep 1;23(133):345-9. doi: 10.1183/09059180.00007813, PMID 25176970.

Fan VS, Ramsey SD, Giardino ND, Make BJ, Emery CF, Diaz PT. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med. 2007 Nov 26;167(21):2345-53. doi: 10.1001/archinte.167.21.2345, PMID 18039994.

Garrod R, Marshall J, Barley E, Jones PW. Predictors of success and failure in pulmonary rehabilitation. Eur Respir J. 2006 Apr 1;27(4):788-94. doi: 10.1183/09031936.06.00130605, PMID 16481381.

Cinciripini PM, Wetter DW, Fouladi RT, Blalock JA, Carter BL, Cinciripini LG. The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy. J Consult Clin Psychol. 2003 Apr;71(2):292-301. doi: 10.1037/0022-006x.71.2.292, PMID 12699023.

Negi H, Sarkar M, Raval AD, Pandey K, Das P. Health-related quality of life in patients with chronic obstructive pulmonary disease in North India. J Postgrad Med. 2014 Jan 1;60(1):7-11. doi: 10.4103/0022-3859.128797, PMID 24625932.

Dodd JW, Chung AW, van den Broek MD, Barrick TR, Charlton RA, Jones PW. Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study. Am J Respir Crit Care Med. 2012 Aug 1;186(3):240-5. doi: 10.1164/rccm.201202-0355OC, PMID 22652026.

Thakur N, Blanc PD, Julian LJ, Yelin EH, Katz PP, Sidney S. COPD and cognitive impairment: the role of hypoxemia and oxygen therapy. Int J Chron Obstruct Pulmon Dis. 2010;5:263-9. doi: 10.2147/copd.s10684, PMID 20856825.

Antonelli Incalzi R, Corsonello A, Pedone C, Trojano L, Acanfora D, Spada A. Drawing impairment predicts mortality in severe COPD. Chest. 2006 Dec 1;130(6):1687-94. doi: 10.1378/chest.130.6.1687, PMID 17166983.

Laurin C, Lavoie KL, Bacon SL, Dupuis G, Lacoste G, Cartier A. Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest. 2007 Jul 1;132(1):148-55. doi: 10.1378/chest.07-0134, PMID 17505033.

Di Marco F, Verga M, Reggente M, Maria Casanova FM, Santus P, Blasi F. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006 Oct 1;100(10):1767-74. doi: 10.1016/j.rmed.2006.01.026, PMID 16531031.

Hilmarsen CW, Wilke S, Engan H, Spruit MA, Rodenburg J, Janssen DJ. Impact of symptoms of anxiety and depression on COPD assessment test scores. Eur Respir J. 2014 Mar 1;43(3):898-900. doi: 10.1183/09031936.00163913, PMID 24114965.

De S. Prevalence of depression in stable chronic obstructive pulmonary disease. Indian J Chest Dis Allied Sci. 2011 Jan 1;53(1):35-9. doi: 10.5005/ijcdas-53-1-35, PMID 21446223.

Dua R, Das A, Kumar A, Kumar S, Mishra M, Sharma K. Association of comorbid anxiety and depression with chronic obstructive pulmonary disease. Lung India off Organ Indian Chest Soc. 2018 Jan;35(1):31-6. doi: 10.4103/lungindia.lungindia_537_16, PMID 29319031.



How to Cite

SOOD, R., G. AHUJA, S. SHARMA, D. D. SHARMA, MONICA, SACHIN, and M. SARKAR. “PSYCHIATRIC COMORBIDITIES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE”. International Journal of Current Pharmaceutical Research, vol. 16, no. 2, Mar. 2024, pp. 38-51, doi:10.22159/ijcpr.2024v16i2.4026.



Original Article(s)